日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者

Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Denileukin Diftitox-Cxdl(一种纯度更高的 Denileukin Diftitox 制剂)在复发或难治性皮肤 T 细胞淋巴瘤患者中的疗效和安全性

Foss, Francine M; Kim, Youn H; Prince, H Miles; Akilov, Oleg E; Querfeld, Christiane; Seminario-Vidal, Lucia; Fisher, David C; Kuzel, Timothy M; Yannakou, Costas K; Geskin, Larisa J; Feldman, Tatyana; Sokol, Lubomir; Allen, Pamela Blair; Dang, Nam Hoang; Cabanillas, Fernando; Wong, Henry K; Ooi, Chean Eng; Xing, Dongyuan; Sauter, Nicholas; Singh, Preeti; Czuczman, Myron; Duvic, Madeleine

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

伊布替尼联合乌布拉利西治疗复发/难治性慢性淋巴细胞白血病的1/1b期研究的长期结果

Ryan, Christine E; Ren, Yue; Tyekucheva, Svitlana; Arnason, Jon E; Boruchov, Adam M; Jacobson, Caron A; Fisher, David C; Miskin, Hari; Sportelli, Peter; Brown, Jennifer R; Davids, Matthew S

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

一项关于商业用途的axicabtagene ciloleucel和lisocabtagene maraleucel在大B细胞淋巴瘤中的真实世界比较研究

Looka, Andrew; Qualls, David A; Matthews, Daniel; Redd, Robert A; Sakellis, Christopher; Duffy, Caitlyn; Dela Cruz, Jamie; Saucier, Anna; Armand, Philippe; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Parry, Erin M; Jacobson, Caron A

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

双重难治性和双重暴露慢性淋巴细胞白血病患者的特征和预后

Yoon, James T; Zhou, Yinglu; Mikhaleva, Mariia; Choi, Daniel S; Fernandes, Stacey M; Armand, Philippe; Bessnow, Amy C; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Odejide, Oreofe O; Parry, Erin M; Qualls, David A; Ryan, Christine E; Sekar, Aswin; Soumerai, Jacob D; Arnason, Jon; Tyekucheva, Svitlana; Davids, Matthew S; Brown, Jennifer R; Ahn, Inhye E

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

一项评估伊布替尼联合氟达拉滨、环磷酰胺和利妥昔单抗作为慢性淋巴细胞白血病一线治疗方案的II期研究的五年随访结果

Ahn, Inhye E; Brander, Danielle M; Ren, Yue; Zhou, Yinglu; Tyekucheva, Svitlana; Walker, Heather A; Black, Robert; Montegaard, Josie; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A; Armand, Philippe; Ng, Samuel Y; Crombie, Jennifer; Fisher, David C; LaCasce, Ann S; Arnason, Jon; Hochberg, Ephraim P; Takvorian, Ronald W; Abramson, Jeremy S; Brown, Jennifer R; Davids, Matthew S

Nitro-sulfinate Reductive Coupling to Access (Hetero)aryl Sulfonamides

硝基亚磺酸盐还原偶联制备(杂)芳基磺酰胺

Sandra E Gatarz, Oliver M Griffiths, Henrique A Esteves, Wenhua Jiao, Peter Morse, Ethan L Fisher, David C Blakemore, Steven V Ley

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

一项针对接受自体干细胞移植的T细胞非霍奇金淋巴瘤患者的帕博利珠单抗II期研究

Merrill, Mwanasha H; Dahi, Parastoo B; Redd, Robert A; McDonough, Mikaela M; Chen, Yi-Bin; DeFilipp, Zachariah; Herrera, Alex F; Fisher, David C; LaCasce, Ann S; Odejide, Oreofe O; Ng, Samuel Y; Jacobson, Caron A; Merryman, Reid W; Kim, Austin I; Nieto, Yago L; Sauter, Craig S; Shah, Gunjan L; Zain, Jasmine M; Armand, Philippe; Jacobsen, Eric D

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

滤泡性淋巴瘤一线化疗免疫治疗期间的中期正电子发射断层扫描

Merryman, Reid W; Michaud, Laure; Redd, Robert; Mondello, Patrizia; Park, Hyesun; Spilberg, Gabriela; Robertson, Matthew; Taranto, Eleanor; Ahmed, Gulrayz; Chase, Matthew; Jeter, Erin; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer; Davids, Matthew S; Fisher, David C; Jacobsen, Eric; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Ng, Samuel Y; Odejide, Oreofe O; Parry, Erin M; Salles, Gilles; Zelenetz, Andrew D; Armand, Philippe; Schöder, Heiko; Jacene, Heather